GLRA
PFE icon

Gerald L. Ray & Associates’s Pfizer PFE Stock Holding History

Gerald L. Ray & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$5.35M Sell
157,898
-12,425
-7% -$399K 0.67% 36
2017
Q2 		$5.43M Sell
170,323
-12,816
-7% -$404K 0.7% 35
2017
Q1 		$5.94M Sell
183,139
-3,720
-2% -$117K 0.81% 30
2016
Q4 		$5.76M Sell
186,859
-12,596
-6% -$385K 0.83% 30
2016
Q3 		$6.41M Buy
199,455
+1,120
+0.6% +$37.5K 0.96% 25
2016
Q2 		$6.63M Buy
198,335
+94
+0% +$3K 1.06% 24
2016
Q1 		$5.58M Buy
198,241
+3,410
+2% +$97.4K 0.9% 29
2015
Q4 		$5.97M Sell
194,831
-686
-0.4% -$21.6K 0.94% 28
2015
Q3 		$5.83M Sell
195,517
-918
-0.5% -$29.4K 0.97% 25
2015
Q2 		$6.25M Buy
196,435
+329
+0.2% +$10.7K 0.95% 27
2015
Q1 		$6.47M Sell
196,106
-1,095
-0.6% -$34.8K 0.97% 24
2014
Q4 		$5.83M Sell
197,201
-4,005
-2% -$115K 0.9% 32
2014
Q3 		$5.64M Buy
201,206
+2,951
+1% +$82.8K 0.92% 32
2014
Q2 		$5.58M Buy
198,255
+13,771
+7% +$393K 0.95% 29
2014
Q1 		$5.62M Sell
184,484
-726
-0.4% -$21.6K 1.02% 29
2013
Q4 		$5.38M Buy
185,210
+1,686
+0.9% +$49.1K 1.01% 29
2013
Q3 		$5M Buy
183,524
+106
+0.1% +$2.88K 1.03% 27
2013
Q2 		$4.87M Buy
+183,418
New +$5.07M 1.09% 27

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Gerald L. Ray & Associates's PFE Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Pfizer (PFE) stake by 7.3% in Q3 2017, selling an estimated $399K and leaving 157,898 shares worth $5.35M. The position accounts for 0.67% of the portfolio, ranked #36.

Gerald L. Ray & Associates first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $6.63M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Gerald L. Ray & Associates held 157,898 shares of Pfizer worth $5.35M as of Q3 2017.
  • Gerald L. Ray & Associates sold 12,425 Pfizer shares in Q3 2017, an estimated $399K.
  • Pfizer made up 0.67% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #36 holding.
  • Gerald L. Ray & Associates first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • Gerald L. Ray & Associates's Pfizer position peaked at $6.63M in Q2 2016.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.